MPM’s Bardon on biotech investing outlook, $850 million oncology fund

Duration: 04:50 1 hr ago

Dr. Christiana Bardon, co-managing partner of MPM’s BioImpact Capital, joins CNBC’s ‘Squawk Box’ to discuss the public and private biotech investing landscape.

Send MSN Feedback

Please give an overall site rating:

Opens in a new window Opens an external site Opens an external site in a new window